
Project Leaders
- Dr. Aamir Khan (Interactive Research & Development)
- Dr. Michael Rich (Partners In Health)
- Dr. KJ Seung (Partners In Health)
- Dr. Francis Varaine (Médecins Sans Frontières)
For bios of the endTB project leaders, see the Leadership page.
Observational Study (Output 1)
Principal Investigators
- Dr. Helena Huerga (Epicentre)
- Dr. Uzma Khan (Interactive Research & Development)
- Dr. KJ Seung (Partners In Health)
First Clinical Trial (Output 2)
Principal Investigators
- Dr. Carole Mitnick (Harvard Medical School)
- Dr. Lorenzo Guglielmetti (Médecins sans Frontières)
Co-Investigators
- Elisabeth Baudin (Epicentre)
- Dr. Maryline Bonnet (Epicentre)
- Dr. Bouke de Jong (Antwerp Institute of Tropical Medicine)
- Dr. Michael Rich (Partners In Health)
- Dr. Alex Telnov (Médecins sans Frontières)
- Dr. Francis Varaine (Médecins sans Frontières)
- Dr. Gabriella Ferlazzo (Médecins sans Frontières)
- Dr. Gustavo Velásquez (Harvard Medical School)
Second Clinical Trial (Output 5)
Principal investigators
- Dr. Carole Mitnick (Harvard Medical School)
- Dr. Lorenzo Guglielmetti, MD (Médecins Sans Frontières)
Co-investigators
- Dr. Maryline Bonnet (Epicentre)
- Elisabeth Baudin (Epicentre)
- Dr. Michael Rich (Partners In Health),
- Dr. Kwonjune Seung (Partners In Health)
- Dr. Gustavo Velásquez (Harvard Medical School)
- Dr. Alex Telnov (Médecins Sans Frontières)
- Dr. Gabriella Ferlazzo (Médecins Sans Frontières)
- Dr. Bouke de Jong (Institute of Tropical Medicine),
- Dr. Uzma Khan (Interactive Research & Development)
- Dr. Francis Varaine (Médecins Sans Frontières)